Correspondence 0001437749-26-018559 from Picard Medical, Inc. (PMI)
Picard Medical, Inc.
Date: May 27, 2026 · CIK: 0002030617 · Accession: 0001437749-26-018559
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296060
Letter
VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Attention: Conlon Danberg RE: Picard Medical, Inc. Registration Statement on Form S-1 Initially Filed on May 20, 2026 File No. 333-296060
Dear Mr. Danberg
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Picard Medical, Inc. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m., Eastern Time on May 29, 2026, or as soon thereafter as practicable.
Please call Michael Blankenship of Winston & Strawn LLP at (713) 651-2678 to provide notice of the effectiveness of the Registration Statement.
Very truly yours,
Picard Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm pmi20260527_corresp.htm PICARD MEDICAL, INC. 1992 East Silverlake Tucson, Arizona 85713 May 27, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Conlon Danberg RE: Picard Medical, Inc. Registration Statement on Form S-1 Initially Filed on May 20, 2026 File No. 333-296060 Dear Mr. Danberg Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Picard Medical, Inc. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m., Eastern Time on May 29, 2026, or as soon thereafter as practicable. Please call Michael Blankenship of Winston & Strawn LLP at (713) 651-2678 to provide notice of the effectiveness of the Registration Statement. Very truly yours, Picard Medical, Inc. By: __ /s/ Patrick NJ Schnegelsberg _______________ Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer cc: Michael Blankenship, Winston & Strawn LLP